CD39 | ApexOnco - Clinical Trials news and analysis

“It's very intuitive and always up-to-date”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Conferences Trial results

22 April 2026

IPH5201 plus Imfinzi in perioperative NSCLC looks better than some but not other historical studies.

Trial results

17 September 2025

Subscribe to CD39

Recent Quick take